Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abbott Laboratories
(NY:
ABT
)
104.82
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
Notable Abbott Laboratories Insider Trades $4.14 Million In Company Stock
September 13, 2021
Michael J Pederson, Senior Vice President at Abbott Laboratories (NYSE:ABT), made a large buy and sell of company shares on September 8, according to a new SEC filing. What...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Got $3,000? Keep It Safe With These 3 Healthcare Stocks
September 13, 2021
They offer products that their customers absolutely can't do without, and they also pay dividends.
Via
The Motley Fool
Where Abbott Laboratories Stands With Analysts
August 21, 2021
Within the last quarter, Abbott Laboratories (NYSE:ABT) has ...
Via
Benzinga
Where Abbott Laboratories Stands With Analysts
July 23, 2021
Analysts have provided the following ratings for Abbott Laboratories (NYSE:
Via
Benzinga
3 Dividend Stocks to Buy and Hold Forever
September 12, 2021
They all have solid dividends plus attractive growth prospects.
Via
The Motley Fool
Why Biden's Action Plan Is Bullish For COVID-19 Testing Stocks
September 10, 2021
On Thursday, President Joe Biden revealed his new COVID-19 action plan, which includes $2 billion in government spending on 280 mi...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
September 08, 2021
A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (...
Via
Benzinga
Exposures
Product Safety
Abbott Labs Stock Strength Rises Into New Percentile As Health Care Giant Expands Organically And Via Acquisition
September 07, 2021
Additionally, Chicago-based Abbott Labs stock carries a near-perfect 98 Composite Rating, putting it in the top 2% of all stocks.
Via
Investor's Business Daily
Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High
September 03, 2021
Abbott Laboratories (NYSE: ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as compared to an average 30-day volume of 4....
Via
Benzinga
Why Shares of Quidel Surged 10% This Week
September 02, 2021
Demand for its COVID tests are rising with cases.
Via
The Motley Fool
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
September 02, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
This May Be Abbott's Billion-Dollar Opportunity
September 02, 2021
Abbott delivered bad news back in June. But the tide has turned.
Via
The Motley Fool
Exposures
COVID-19
Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study
August 30, 2021
Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer...
Via
Benzinga
See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests
August 27, 2021
CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The...
Via
Benzinga
Exposures
COVID-19
Healthcare Stocks Hit New Highs but Small Caps Lag
August 23, 2021
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field.
Via
Talk Markets
Abbott Destroyed Several COVID Test Cards, Now Faces Diminished Capacity: NYT
August 23, 2021
When demand for rapid COVID-19 screening dropped earlier this year, Abbott Laboratories (NYSE: ABT) lowered its financial outlook for full-year 2021 and ...
Via
Benzinga
Exposures
COVID-19
AbbVie: Dividend Stock to Buy?!
August 21, 2021
The quest to find undervalued dividend stocks to buy in this hot stock market continues. The S&P 500 continues to trend higher and set record highs, even though we’ve had a few down days recently.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
FDA Approves Abbott's Atrial Fibrillation Device For LAA Occlusion
August 16, 2021
The
Via
Benzinga
Exposures
Product Safety
How Spinoffs Affect Your Stocks
August 11, 2021
When stocks you own spins off a segment or division of its business, the company you own changes. This can change not only the future prospects of the company you own but also its historical...
Via
Talk Markets
2 Stocks That Could Turn $200,000 Into $1,000,000 in 10 Years
August 10, 2021
Both of these companies know something about beating the market.
Via
The Motley Fool
1 Healthcare Dividend Giant to Bank On Right Now
August 06, 2021
The pipeline and consistent dividend history of this Dividend Aristocrat mean its payout is likely to remain strong.
Via
The Motley Fool
Moderna’s (MRNA) Massive Market Cap
August 04, 2021
As could have been expected in the midst of a global pandemic, one of the most rapidly growing companies has been vaccine producer Moderna.
Via
Talk Markets
Got $5,000? Buy and Hold These 3 Market-Beating Stocks
August 04, 2021
They're likely to continue to outperform the market.
Via
The Motley Fool
Analyzing Abbott Laboratories's Unusual Options Activity
July 28, 2021
Shares of Abbott Laboratories (NYSE:ABT) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $120.62. Sentiment:...
Via
Benzinga
Understanding Abbott Laboratories's Unusual Options Activity
July 23, 2021
On Friday, shares of Abbott Laboratories (NYSE:ABT) saw unusual options activity. After the option alert, the stock price moved up to $120.16. Sentiment: BULLISH Option Type:...
Via
Benzinga
Analyzing Abbott Laboratories's Unusual Options Activity
July 23, 2021
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Friday. The stock price moved up to $120.17 following the option alert. Sentiment: BULLISH Option...
Via
Benzinga
Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
July 22, 2021
ABT earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
...
24
25
26
27
28
29
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.